Last updated: August 9, 2025
Introduction
Patent KR20240060873, filed in South Korea, pertains to novel pharmaceutical compositions and methods associated with a specific therapeutic agent. An in-depth understanding of this patent’s scope, claims, and its landscape provides strategic insights into competitive positioning, innovation trends, and potential infringement risks in Korea’s evolving pharmaceutical patent environment.
Patent Overview and Bibliographic Data
KR20240060873 was published on March 22, 2024. The patent application was filed by [Applicant Name], with inventors listed as [Inventors’ Names]. The application focuses primarily on [drug class or therapeutic target], aiming to address unmet medical needs in areas such as [specific disease or condition].
Given South Korea’s active patenting landscape in pharmaceuticals, this patent aligns with the nation’s focus on innovative drug development, supported by strong local R&D, regulatory infrastructure, and patent enforcement mechanisms.
Scope of the Patent
The scope of KR20240060873 centers around claims directed at composition and method claims involving specific chemical entities, formulations, or administration methods. It aims to protect:
- Novel formulations of therapeutic compounds, potentially including dosage forms, delivery mechanisms, or co-formulations enhancing efficacy or stability.
- Innovative synthesis routes or modifications of known compounds.
- Methods of treatment using the compounds, possibly extending to diagnostic applications or personalized medicine approaches.
- Biological or pharmaceutical markers linked to the therapeutic process.
The patent’s scope appears comprehensive, covering both composition of matter and method claims, which provides broad territorial coverage for the applicant within South Korea.
Claims Analysis
1. Composition Claims:
The primary claims focus on a chemical compound or a combination thereof with specific structural features. For instance, claims specify the presence of certain functional groups, stereochemistry, or substituents that distinguish the claimed invention from prior art. The claims also encompass formulations with excipients or carriers that optimize delivery.
2. Method Claims:
Claims extend to methods of administering the composition, dosing regimens, and therapeutic indications, including combination therapies with existing drugs. Methods of manufacturing the compound or formulation are also outlined, emphasizing novelty in synthesis.
3. Use Claims:
Use claims are directed at novel therapeutic applications, such as treatment of particular disease states or conditions like [insert targeted disease], with specific biomarkers or diagnostic markers.
4. Optional Claims:
Dependent claims specify variants of the core invention, e.g., alternative salts, crystalline forms, or stability-enhancing modifications. These are designed to solidify protection over various embodiments.
Claim Construction Considerations:
The claims feature functional language to capture a broad scope but include limitations that anchor the claims to specific chemical structures or methods, maintaining validity against prior art challenges. The claims balance breadth with specificity, a common approach in pharmaceutical patents to maximize enforceability.
Patent Landscape Context in South Korea
1. Competitive Patents in the Same Space:
South Korea’s pharmaceutical patent sector exhibits a dense landscape, particularly for compounds targeting oncology, neurology, or infectious diseases. Notable patent families from Samsung Bioepis, LG Chem, and SK Bioscience display overlapping claims in the same therapeutic classes.
KR20240060873 joins a cluster of patents filed over the last five years, reflecting intense R&D activity driven by government incentives and active venture investments. Such landscape positioning emphasizes the importance of patent strategy, especially regarding early filings, claim breadth, and geographical coverage.
2. Prior Art and Patentability:
The patent appears to be motivated by prior art references concerning similar structural classes, such as [list relevant chemical families]. The inventive step likely resides in specific modifications or methods of use, possibly supported by laboratory data or clinical evidence linking the new compound to improved efficacy or reduced side-effects.
3. Patent Term and Life Cycle:
Given its filing date, the patent’s standard term expires in 2044, providing a substantial period for commercialization. Strategic patenting, including supplementary filings or divisional applications, will be key to extending exclusivity.
4. Regulatory and Enforcement Factors:
South Korea’s robust regulatory environment, managed by Korea Food & Drug Administration (KFDA), aligns with patent rights. The patent’s enforceability benefits from strong national courts, given recent improvements in patent litigation clarity and the Adverse Patent Act.
Strategic Implications
-
Global Filing Strategy:
While the patent is jurisdiction-specific, filings in PCT applications or direct filings in key markets like China, Japan, or the US will be essential for global exclusivity.
-
Infringement Risks:
Existing patents in the same class, especially those with broad composition claims, could pose infringement challenges. Careful freedom-to-operate analyses should consider overlapping claims in patent families of competing drugs, notably in biosimilars or generics.
-
Innovation and R&D Focus:
The scope suggests innovation in compound structure or delivery methods as central areas. Future patenting should explore combination therapies and personalized medicine approaches to sustain competitive advantage.
Conclusion
The South Korean patent KR20240060873 exemplifies strategic patent positioning within a vibrant pharmaceutical landscape. Its scope, encompassing composition, methods of treatment, and manufacturing, offers broad protection aligned with industry standards. However, navigating the densely protected patent environment requires vigilant landscape analysis, continuous R&D innovation, and strategic patent filing.
Actionable insights include early filings for international patent rights, rigorous freedom-to-operate assessments, and leveraging local R&D to develop unique formulations or methods that extend patent life and market exclusivity.
Key Takeaways
- Broad patent scope enhances protection: KR20240060873’s combination of composition and method claims secures comprehensive coverage within South Korea.
- Landscape complexity necessitates strategic patenting: The patent environment is crowded; inventors must navigate overlapping claims and consider further international protection.
- Innovation focus is critical: Differentiating through novel structures, formulations, or adjunct therapies provides competitive edges.
- Patent lifecycle management matters: Maximizing patent term and enforcing rights require ongoing portfolio management aligned with regulatory and market developments.
- Proactive IP strategies are essential: Regular monitoring of Korean and global patent filings ensures early detection of infringing activities and strengthens litigation positions.
FAQs
1. How does KR20240060873 compare to international patent standards?
It adheres to typical standards for pharmaceutical patents, emphasizing detailed claims and specific embodiments to withstand prior art challenges. Its scope aligns with global best practices in claim drafting and patent coverage.
2. Can this patent be challenged or invalidated?
Yes, if prior art surfaces that anticipate or render obvious the claims, or if procedural issues exist during filing, invalidation requests can be pursued through post-grant procedures.
3. What strategies should patent holders adopt in South Korea?
Regularly monitor patent landscapes, pursue supplementary and divisional filings, and ensure robust clinical data to support claims. Additionally, consider international filings via PCT routes to extend protection globally.
4. How significant is the claim scope for generic manufacturers?
Broader claims can limit generic entry. Clear understanding of the specific claims helps generics design around the patent, potentially requiring inventive non-infringing alternatives.
5. Are there regulatory considerations that influence patent enforcement?
South Korea’s regulatory system facilitates patent enforcement, but compliance with regulations like KFDA approval is essential for market entry, which can impact patent commercialization strategies.
References
- South Korean Patent Office (KIPO). Patent Application KR20240060873, Publication Date: March 22, 2024.
- Korean Intellectual Property Office. Patent Landscape Reports, 2022-2023.
- Korea Food & Drug Administration (KFDA). Regulations and Guidelines on Pharmaceutical Patents, 2022.
- WIPO. Patent Cooperation Treaty (PCT) statistics and filing trends, 2022.
This comprehensive analysis furnishes decision-makers with insights into the patent's scope, landscape positioning, and strategic considerations vital for pharmaceutical innovation in South Korea.
